Kalaris Therapeutics KLRS
NASDAQ KLRS
$4.15 +0.03 (+0.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Kalaris Therapeutics (KLRS) Property, Plant & Equipment (Net) (2019 - 2023)

Kalaris Therapeutics (KLRS) Property, Plant & Equipment (Net) (2019 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Kalaris Therapeutics 100.19 Mn 100.19 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 673,000.00
Sep 30, 2023 673,000.00
Jun 30, 2023 759,000.00
Jun 30, 2023 759,000.00
Mar 31, 2023 844,000.00
Mar 31, 2023 844,000.00
Dec 31, 2022 930,000.00
Dec 31, 2022 930,000.00
Sep 30, 2022 943,000.00
Sep 30, 2022 943,000.00
Jun 30, 2022 997,000.00
Jun 30, 2022 997,000.00
Mar 31, 2022 1.08 Mn
Mar 31, 2022 1.08 Mn
Dec 31, 2021 1.55 Mn
Dec 31, 2021 1.55 Mn
Sep 30, 2021 1.11 Mn
Sep 30, 2021 1.11 Mn
Jun 30, 2021 1.22 Mn
Jun 30, 2021 1.22 Mn